RNA interference provides powerful tools for controlling gene expression in cultured cells. Whether RNAi will provide similarly powerful drugs is unknown. Lessons from development of antisense oligonucleotide drugs may provide some clues.
References
Fire, A. et al. Nature 391, 806–811 (1998).
Sen, G.L. & Blau, H.M. FASEB J. 20, 1293–1299 (2006).
Tomari, Y. & Zamore, P.D. Genes Dev. 19, 517–529 (2005).
Braasch, D.A. & Corey, D.R. Biochemistry 41, 4503–4510 (2002).
Baker, B.F. et al. J. Biol. Chem. 272, 11994–12000 (1997).
Wu, H. et al. J. Biol. Chem. 279, 17181–17189 (2004).
McKay, R.A. et al. J. Biol. Chem. 274, 1715–1722 (1999).
Eckstein, F. Biochimie 84, 841–848 (2002).
Summerton, J. Biochim. Biophys. Acta 1489, 141–158 (1999).
Braasch, D.A. et al. Bioorg. Med. Chem. Lett. 14, 1139–1143 (2004).
Rusckowski, M., Ou, T., Roskey, A. & Agrawal, S. Antisense Nucleic Acid Drug Dev. 10, 333–345 (2000).
Braasch, D.A. et al. Biochemistry 42, 7967–7975 (2003).
Harborth, J. et al. Antisense Nucleic Acid Drug Dev. 13, 83–105 (2003).
Allerson, C.R. et al. J. Med. Chem. 48, 901–904 (2005).
Manoharan, M. Curr. Opin. Chem. Biol. 8, 570–579 (2004).
Zhang, H. et al. Nat. Biotechnol. 18, 862–867 (2000).
Song, E. et al. Nat. Med. 9, 347–351 (2003).
Crooke, R.M. et al. J. Lipid Res. 46, 872–884 (2005).
Soutschek, J. et al. Nature 432, 173–178 (2004).
Koller, E. et al. Nucleic Acids Res. 34, 4467–4476 (2006).
Grimm, D. et al. Nature 441, 537–541 (2006).
Ng, E.W. et al. Nat. Rev. Drug Discov. 5, 123–132 (2006).
Brown, D.M. et al. N. Engl. J. Med. 355, 1432–1444 (2006).
Paroo, Z. & Corey, D.R. Trends Biotechnol. 22, 390–394 (2004).
Acknowledgements
The author has been a consultant for Isis Pharmaceuticals. The author acknowledges support from the US National Institutes of Health (NIGMS 60642 and 73042) and the Robert A. Welch Foundation (I-1244).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Corey, D. RNA learns from antisense. Nat Chem Biol 3, 8–11 (2007). https://doi.org/10.1038/nchembio0107-8
Issue Date:
DOI: https://doi.org/10.1038/nchembio0107-8
- Springer Nature America, Inc.
This article is cited by
-
The chemical evolution of oligonucleotide therapies of clinical utility
Nature Biotechnology (2017)
-
Patterns of technological innovation in biotech
Nature Biotechnology (2012)
-
Production and characterization of a recombinant single-chain antibody against Hantaan virus envelop glycoprotein
Applied Microbiology and Biotechnology (2010)
-
Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs
Nature Biotechnology (2009)
-
Altering Arabidopsis Oilseed Composition by a Combined Antisense‐Hairpin RNAi Gene Suppression Approach
Journal of the American Oil Chemists' Society (2009)